In the evolving landscape of HIV/AIDS management, the Platinum Health Medical Scheme, under the guidance of Dr. Katlego Lekganyane, is redefining HIV care by focusing on the overall health and sustainability of the patient, transcending the traditional viral suppression model. This shift is critical as the life expectancy for people living with HIV (PLWH) continues to rise, necessitating a comprehensive approach to managing comorbidities, medication-related risks, and long-term organ health.
The medical scheme has achieved remarkable success in meeting and exceeding the UNAIDS targets for HIV management — commonly known as 95/95/95. This goal aims for 95% of PLWH to know their status, 95% of those diagnosed to receive antiretroviral therapy (ART), and 95% of those on ART to achieve viral suppression.
The scheme has expanded these efforts, striving for 97/97/97, thereby reducing HIV-related complications, enhancing quality of life, and curbing transmission rates.
The success in HIV management has significantly increased life expectancy for PLWH, bringing forth new challenges such as aging — related illnesses and polypharmacy. To address these, the scheme emphasizes patient-centred care and treatment integration, ensuring a holistic view of the patient’s health. By transitioning patients to newer therapies, the scheme is not only reducing long-term healthcare costs and disability burdens but also mitigating the risks associated with aging-related complications such as chronic kidney disease and bone density loss.
These proactive measures include the introduction of kidney — friendly and bone density-preserving HIV treatments.
The introduction of Pre Exposure Prophylaxis (PrEP) and Post Exposure Prophylaxis (PEP) has also been instrumental in reducing new HIV infections, further reinforcing the importance of innovative prevention methods.
Additionally, digital health technology plays a crucial role in data — driven decisions, enhancing treatment optimization and care coordination.
The management of HIV has also had a positive impact on Disability — Adjusted Life Years (DALYs), reducing the morbidity and mortality associated with the disease. By promoting good adherence and longer quality of life, HIV care enables economically active individuals to remain productive and contributes to the economic sustainability of the country.
The ongoing innovation in HIV treatment, such as ultra — long-acting (ULA) therapies, is another testament to the commitment to improving the overall health and well-being of PLWH.
The advancements in treatment could lead to improved adherence and a reduced frequency of doctor visits, ultimately lowering the overall burden of living with HIV.
The future of HIV/AIDS management lies in a holistic approach that considers not just viral suppression, but also the long-term quality of life and sustainability of the healthcare system. Through coordinated care, investment in primary healthcare, and adherence to environmental, social, and governance (ESG) principles, the fight against HIV/AIDS looks increasingly hopeful.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: africa
Source: SG Editor
